Michael S. Weiss - 29 Jul 2022 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
Director
Signature
/s/ Matthew Wein, Attorney-in-Fact
Issuer symbol
MBIO
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
4
Filing time
03 Apr 2023, 16:48:21 UTC
Previous filing
22 Jul 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Award $0 +71,664 +112% $0.000000 135,861 29 Jul 2022 See Note 3 F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date.
F2 Includes restricted share units, which vest over various time periods.
F3 The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.